A detailed history of Ehrlich Financial Group transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ehrlich Financial Group holds 10,504 shares of EW stock, worth $740,321. This represents 0.49% of its overall portfolio holdings.

Number of Shares
10,504
Previous 10,284 2.14%
Holding current value
$740,321
Previous $950 Million 27.03%
% of portfolio
0.49%
Previous 0.75%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$59.7 - $93.78 $13,134 - $20,631
220 Added 2.14%
10,504 $693 Million
Q2 2024

Jul 12, 2024

BUY
$84.3 - $94.31 $299,770 - $335,366
3,556 Added 52.85%
10,284 $950 Million
Q1 2024

Apr 15, 2024

BUY
$72.54 - $95.56 $187,951 - $247,595
2,591 Added 62.63%
6,728 $643 Million
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $255,294 - $321,693
4,137 New
4,137 $315 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ehrlich Financial Group Portfolio

Follow Ehrlich Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ehrlich Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Ehrlich Financial Group with notifications on news.